EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metronidazole-mediated gut anaerobe remodeling is associated with transplant rejection

Yanzhuo Liu, Yang Tian, Chunlan Pu, Yan Yang, Xinhao Peng, Hai Zhu, Jia Fan, Rongke Zhang, Hao Yuan, Jun Zhang, Jianyu Liu, Gaoping Zhao

Frontiers in Cellular and Infection Microbiology · 18.08.2026 · 16

DOI: 10.3389/fcimb.2026.1874387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.08.2026. Verfasst von Yanzhuo Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Metronidazole, Graft Rejection, Gastrointestinal Microbiome, Bacteria, Anaerobic. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The gut microbiome has emerged as a potential modulator of transplant rejection. However, the relevance of anaerobe-associated gut microbial communities to transplant rejection responses remains unclear.

Methods

In a murine islet transplantation model, we assessed the effects of metronidazole pretreatment on allograft survival and function. 16S rRNA sequencing was performed to characterize treatment-associated changes in gut microbial composition. Separately, an exploratory two-sample MR analysis using human GWAS data was performed to prioritize gut microbial taxa associated with a composite outcome of transplant failure or rejection. Biological annotation was subsequently used to prioritize candidate host pathways. Immunohistochemistry and flow cytometry were used to evaluate post-transplant immune responses after metronidazole pretreatment.

Results

Metronidazole treatment remodeled gut microbiota composition and significantly delayed islet allograft rejection. MR analyses identified several anaerobe-associated gut microbial taxa potentially relevant to transplant rejection risk, including the family Defluviitaleaceae and the genera Intestinibacter , Bilophila , Ruminococcus and Eubacterium fissicatena . Integrative biological annotation highlighted glycosylation-related pathways and prioritized ST3GAL4 for subsequent expression assessment in the murine transplant model. Furthermore, metronidazole treatment reduced CD4 + T-cell infiltration around the allograft and Th17-related inflammatory responses.

Conclusion

Altogether, our findings document gut microbial remodeling and delayed allograft rejection following metronidazole pretreatment. These findings are hypothesis-generating and warrant further mechanistic investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetronidazoleGraft RejectionGastrointestinal MicrobiomeBacteria, AnaerobicIslets of Langerhans TransplantationAnimalsMiceRNA, Ribosomal, 16SHumansGraft SurvivalMice, Inbred C57BLDisease Models, AnimalMale

Stichwörter der Autor:innen

Th17 responseanaerobic bacteriaglycosylationmetronidazoletransplant rejection

Substanzen

MetronidazoleRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Oncology, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
  • Medical Research Center, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
  • The Seventh People's Hospital of Chengdu Affiliated Cancer Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
  • Department of Gastrointestinal Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Sichuan Province

Zitieren

APA

Liu, Y., Tian, Y., Pu, C., Yang, Y., Peng, X., Zhu, H., Fan, J., Zhang, R., Yuan, H., Zhang, J., Liu, J., & Zhao, G. (2026). Metronidazole-mediated gut anaerobe remodeling is associated with transplant rejection. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1874387

Vancouver

Liu Y, Tian Y, Pu C, Yang Y, Peng X, Zhu H, et al. Metronidazole-mediated gut anaerobe remodeling is associated with transplant rejection. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1874387

BibTeX
@article{Liu2026,
  author = {Liu, Yanzhuo and Tian, Yang and Pu, Chunlan and Yang, Yan and Peng, Xinhao and Zhu, Hai and Fan, Jia and Zhang, Rongke and Yuan, Hao and Zhang, Jun and Liu, Jianyu and Zhao, Gaoping},
  title = {Metronidazole-mediated gut anaerobe remodeling is associated with transplant rejection},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1874387}
}
Kostenlos starten →